The role of cellular immune response in Theiler's virus-induced central nervous system demyelination

Journal of Neuroimmunology

Volumn 147, Issue 1-2, 2004, Pages 73-77

  Njenga, M Kariuki ^a   Marques, Cristina ^a   Rodriguez, Moses ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Adhesion molecules; Cellular immune response; Demyelination; Theiler's syndrome

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PADGEM PROTEIN;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL PARASITOSIS; ANIMAL TISSUE; B LYMPHOCYTE; BLOOD; BRAIN; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DEMYELINATING DISEASE; DEMYELINATION; DISEASE PREDISPOSITION; FLOW CYTOMETRY; GENETICS; IMMUNOCOMPETENT CELL; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTIC INFILTRATION; METABOLISM; METHODOLOGY; MOUSE; MOUSE STRAIN; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TRANSGENIC MOUSE; VIROLOGY; VIRUS REPLICATION;

EID: 1642575045     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.10.042     Document Type: Conference Paper

References (26)

1. + T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J. Gen. Virol. 73:1992;1861-1865.
2. Clatch R.J., Melvold R.W., Miller S.D., Lipton H.L. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135:1985;1408-1414.
3. Clatch R.J., Lipton H.L., Miller S.D. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 136:1986;920-927.
4. Dailey M.O., Fathman C.G., Butcher E.C., Pillemer E., Weisman I. Abnormal migration of T lymphocyte clones. J. Immunol. 128:1982;2134-2136.
5. Dal Canto M.C., Lipton H.L. Multiple sclerosis. Animal model: Theiler's virus infection in mice. Am. J. Pathol. 88:1977;497-500.
6. Dittel B.N., LeBien T.W. The growth response to IL-7 during normal human B cell ontogeny is restricted to B-lineage cells expressing CD34. J. Immunol. 154:1995;58-67.
7. Fiette L., Aubert C., Brahic M., Rossi C.P. Theiler's virus infection of beta 2-microglobulin-deficient mice. J. Virol. 67:1993;589-592.
8. Inoue A., Choe Y.K., Kim K.S. Analysis of antibody responses to predominant linear epitopes on Theiler's murine encephalomyelitis virus. J. Virol. 68:1994;3324-3333.
9. 121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J. Virol. 73:1999;3702-3708.
10. Kim B.S., Choe Y.K., Crane M.A., Jue C.R. Identification and localization of a limited number of predominant conformation-independent antibody epitopes of Theiler's murine encephalomyelitis virus. Immunol. Lett. 31:1992;199-205.
11. Kurtz C.I., Sun X.M., Fujinami R.S. B-lymphocyte requirement for vaccine-mediated protection from Theiler's murine encephalomyelitis virus-induced central nervous system disease. J. Virol. 69:1995;5152-5155.
12. b mice inhibits resistance to virus-induced demyelination. J. Virol. 76:2002;7799-7811.
13. Lindsley M.D., Rodriguez M. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J. Immunol. 142:1989;2677-2682.
14. Lipton H.L. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect. Immun. 11:1975;1147-1155.
15. Mackay C.R. Homing of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5:1993;423-427.
16. Monteyne P., Bureau J.F., Brahic M. The infection of mouse by Theiler's virus: from genetics and immunology. Immunol. Rev. 159:1997;163-176.
17. + T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice. J. Immunol. 156:1996;1276-1283.
18. Pullen L.C., Miller S.D., Dal Canto M.C., Kim B.S. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23:1993;2287-2293.
19. Rigby S., Dailey M.O. Traffic of L-selectin-negative T cells to sites of inflammation. Eur. J. Immunol. 30:2000;98-107.
20. Rivera-Quinones C., McGavern D., Schmelzer J.D., Hunter S.F., Low P.A., Rodriguez M. Absence of neurologic deficits following extensive demyelination in class I-deficient murine model of multiple sclerosis. Nat. Med. 4:1998;187-193.
21. Rodriguez M., Sriram S. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J. Immunol. 140:1988;2950-2955.
22. Rodriguez M., Oleszak E., Leibowitz J. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit. Rev. Immunol. 7:1987;325-366.
23. b mice deficient in β2-mcroglubulin. J. Immunol. 151:1993;266-276.
24. Rodriguez M., Pavelko K.D., Njenga M.K., Logan W.C., Wettstein P.J. The balance between persistent infection and immune cells determines demyelination. J. Immunol. 157:1996;5699-5709.
25. Wolf M.L., Weng W.K., Stieglbauer K.T., Shah N., LeBien T.W. Functional effect of IL-7-enhanced CD19 expression on human B cell precursors. J. Immunol. 151:1993;138-148.
26. 233-244. J. Immunol. 153:1994;4508-4519.